Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""JAMA oncology [JAMA Oncol] NLMUID: 101652861"" wg kryterium: JN


Tytuł :
Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma-Renewed Enthusiasm and a Lingering Challenge.
Autorzy :
DaSilva LL; Department of Medicine, MetroWest Medical Center/Tufts University School of Medicine, Framingham, Massachusetts.
Aguiar PN Jr; Instituto Oncoclinicas, São Paulo, Brazil.
de Lima Lopes G; Department of Medicine, Jackson Memorial Hospital/University of Miami, Miami, Florida.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 14. Date of Electronic Publication: 2021 Sep 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Trends in Late Mortality and Life Expectancy After Allogeneic Blood or Marrow Transplantation Over 4 Decades: A Blood or Marrow Transplant Survivor Study Report.
Autorzy :
Bhatia S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Dai C; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Landier W; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Hageman L; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Wu J; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Schlichting E; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Siler A; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Funk E; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Hicks J; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Bosworth A; Population Sciences, City of Hope, Duarte, California.
Te HS; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis.
Francisco L; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham.
Bhatia R; Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Alabama at Birmingham.
Salzman D; Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Alabama at Birmingham.
Goldman FD; Division of Pediatric Hematology, Oncology, and Bone Marrow Transplantation, University of Alabama at Birmingham.
Forman SJ; Population Sciences, City of Hope, Duarte, California.
Weisdorf DJ; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis.
Wong FL; Population Sciences, City of Hope, Duarte, California.
Arora M; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis.
Armenian SH; Population Sciences, City of Hope, Duarte, California.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 09. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Inferential Challenges for Real-world Evidence in the Era of Routinely Collected Health Data: Many Researchers, Many More Hypotheses, a Single Database.
Autorzy :
Panagiotou OA; Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island.; Center for Gerontology & Healthcare Research and Center for Evidence Synthesis in Health, Brown University School of Public Health, Providence, Rhode Island.
Heller R; Department of Statistics and Operations Research, Tel-Aviv University, Tel-Aviv, Israel.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 09. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Life Expectancy After Allogeneic Stem Cell Transplant-In It for the Long Haul?
Autorzy :
Gowda L; Section of Hematology, Department of Medicine, Yale University School of Medicine, Yale Comprehensive Cancer Center, New Haven, Connecticut.
Seropian S; Section of Hematology, Department of Medicine, Yale University School of Medicine, Yale Comprehensive Cancer Center, New Haven, Connecticut.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 09. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?
Autorzy :
Kosaka M; Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Mizutani T; Department of Medical Oncology, Kyorin University Faculty of Medicine, Tokyo, Japan.
Ishiki H; Department of Palliative Medicine, National Cancer Center Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 09. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?-Reply.
Autorzy :
Falandry C; GINECO, Laboratoire CarMEN de l'Université de Lyon, Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France, Lyon-Sud University Hospital, Lyon, France.
Freyer G; GINECO, Hospices Civils de Lyon, Lyon, France.
Pujade-Lauraine E; ARCAGY-GINECO, Université Paris Descartes, AP-HP, Paris, France.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 09. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
What Is the Optimal Treatment for Vulnerable Older Women With Ovarian Cancer?
Autorzy :
Ito K; Department of Breast and Endocrine Surgery, National Center for Global Health and Medicine, Tokyo, Japan.
Shimomura A; Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 09. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Neoadjuvant Endocrine Therapy in Clinical Practice: A Review.
Autorzy :
Sella T; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
Weiss A; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
Mittendorf EA; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
King TA; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.; Division of Breast Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
Pilewskie M; Breast Surgery Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Giuliano AE; Division of Surgical Oncology, Department of Surgery, Cedars-Sinai Health System, Los Angeles, California.
Metzger-Filho O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Breast Oncology Program, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 09. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
Autorzy :
Zhang Y; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Fakhry C; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.; Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University, Baltimore, Maryland.
D'Souza G; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02, pp. e212907. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Inserting Ensartinib Into the Starting Lineup for ALK-Rearranged Lung Cancer-A Likely Limited Role on a Deep Bench.
Autorzy :
Dagogo-Jack I; Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston.; Harvard Medical School, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
COVID-19 and Cancer: A Review of the Registry-Based Pandemic Response.
Autorzy :
Desai A; Division of Medical Oncology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.; Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Mohammed TJ; Department of Medicine, University of Connecticut, Farmington.
Duma N; Division of Hematology, Department of Medicine, Medical Oncology and Palliative Care, University of Wisconsin, Madison.
Garassino MC; Department of Medicine, University of Chicago, Chicago, Illinois.
Hicks LK; Division of Hematology/Oncology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
Kuderer NM; Advanced Cancer Research Group, Seattle, Washington.
Lyman GH; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Oncology, Department of Medicine, University of Washington, Seattle.
Mishra S; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Pinato DJ; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Division of Oncology, Department of Translational Medicine, Piemonte Orientale University, Novara, Italy.
Rini BI; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Peters S; Oncology Department, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Warner JL; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Whisenant JG; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Wood WA; Division of Hematology, Department of Medicine, University of North Carolina at Chapel Hill.
Thompson MA; Aurora Cancer Care, Advocate Aurora Health, Milwaukee, Wisconsin.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population.
Autorzy :
Wang X; Department of Biostatistics, Harvard University, Boston, Massachusetts.
Kim DH; Hinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts.
Wei LJ; Department of Biostatistics, Harvard University, Boston, Massachusetts.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population.
Autorzy :
Mizutani T; Department of Medical Oncology, Kyorin University Faculty of Medicine, Shinkawa, Mitaka-shi, Tokyo, Japan.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Information Blocking and Oncology: Implications of the 21st Century Cures Act and Open Notes.
Autorzy :
Waseem N; Johns Hopkins Sidney Kimmel Cancer Center at Bayview Medical Center, Baltimore, Maryland.
Kircher S; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Feliciano JL; Johns Hopkins Sidney Kimmel Cancer Center at Bayview Medical Center, Baltimore, Maryland.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Quantifying and Interpreting Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Cancer Control for Advanced Gastroesophageal Cancer Among an Older Population-Reply.
Autorzy :
Hall PS; University of Leeds, Leeds, United Kingdom.; University of Edinburgh, Edinburgh, United Kingdom.
Cairns DA; University of Leeds, Leeds, United Kingdom.
Seymour MT; University of Leeds, Leeds, United Kingdom.; Leeds Teaching Hospitals NHS Trust, United Kingdom.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Unilateral Leg Swelling in a Young Woman.
Autorzy :
Lambden JP; McGaw Medical Center of Northwestern University, Chicago, Illinois.
Au DK; McGaw Medical Center of Northwestern University, Chicago, Illinois.; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Didwania AD; McGaw Medical Center of Northwestern University, Chicago, Illinois.; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Ensartinib vs Crizotinib for Patients With Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Randomized Clinical Trial.
Autorzy :
Horn L; Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.; Now with Global Clinical Head for Lung Cancer and Lung Cancer Strategy, AstraZeneca, Nashville, Tennessee.
Wang Z; Department of Thoracic Medical Oncology, Peking University Cancer Hospital and Institute, Beijing, China.
Wu G; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Poddubskaya E; Clinical Center for Oncology, I. M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.; Clinical Center VitaMed, Moscow, Russia.
Mok T; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China.
Reck M; Lung Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
Wakelee H; Department of Medicine, Division of Oncology and Stanford Cancer Institute, Stanford University, Stanford, California.
Chiappori AA; Thoracic Oncology Program, Moffitt Cancer Center, Tampa, Florida.
Lee DH; Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Breder V; Department of Chemotherapy No. 17, N. N. Blokhin Russian Cancer Research Center, Moscow, Russia.
Orlov S; Department of Biochemistry, Pavlov First Saint Petersburg State Medical University, St Petersburg, Russia.
Cicin I; Department of Medical Oncology, Faculty of Medicine, Trakya University, Edirne, Turkey.
Cheng Y; Department of Thoracic Oncology, Jilin Cancer Hospital, Changchun, China.
Liu Y; Department of Medical Oncology, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Fan Y; Thoracic Tumor Center, Zhejiang Cancer Hospital, Hangzhou, China.
Whisenant JG; Division of Hematology and Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee.
Zhou Y; Biometrics, Xcovery Holdings Inc, Palm Beach Gardens, Florida.
Oertel V; Clinical Operations, Xcovery Holdings Inc, Palm Beach Gardens, Florida.
Harrow K; Clinical Operations, Xcovery Holdings Inc, Palm Beach Gardens, Florida.; Now with EQRx, Cambridge, Massachusetts.
Liang C; Clinical Science, Xcovery Holdings Inc, Palm Beach Gardens, Florida.
Mao L; Clinical Development, Xcovery Holdings Inc, Palm Beach Gardens, Florida.; Now with Sino Biopharmaceutical Ltd, Beijing, China.
Selvaggi G; Clinical Development, Xcovery Holdings Inc, Palm Beach Gardens, Florida.
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Sep 02. Date of Electronic Publication: 2021 Sep 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Managing Pulmonary Oligometastatic Disease with Stereotactic Body Radiation Therapy-Moving the Field Forward 1 Organ at a Time.
Autorzy :
Amini A; Department of Radiation Oncology, City of Hope National Medical Center, Duarte, California.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Aug 29. Date of Electronic Publication: 2021 Aug 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II): The Trans Tasman Radiation Oncology Group 13.01 Phase 2 Randomized Clinical Trial.
Autorzy :
Siva S; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
Bressel M; Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Victoria, Australia.
Mai T; Radiation Oncology Centre, Princess Alexandra Hospital, Queensland, Australia.
Le H; Department of Radiation Oncology, Royal Adelaide Hospital, South Australia, Australia.
Vinod S; Cancer Therapy Centre, Liverpool Hospital, New South Wales, Australia.
de Silva H; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Macdonald S; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Skala M; Royal Hobart Hospital, Tasmania, Australia.
Hardcastle N; Department of Physical Sciences, Peter MacCallum Cancer Centre, Victoria, Australia.
Rezo A; Canberra Hospital, Garran, Australian Capital Territory, Australia.
Pryor D; Radiation Oncology Centre, Princess Alexandra Hospital, Queensland, Australia.
Gill S; Sir Charles Gairdner Hospital, Western Australia, Australia.
Higgs B; Department of Radiation Oncology, Royal Adelaide Hospital, South Australia, Australia.
Wagenfuehr K; Trans Tasman Radiation Oncology Group (TROG) Cancer Research, New South Wales, Australia.
Montgomery R; Trans Tasman Radiation Oncology Group (TROG) Cancer Research, New South Wales, Australia.
Awad R; Royal Hobart Hospital, Tasmania, Australia.
Chesson B; Department of Radiation Therapy, Peter MacCallum Cancer Centre, Victoria, Australia.
Eade T; Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, New South Wales, Australia.
Wong W; Department of Radiation Oncology, Prince of Wales Hospital, New South Wales, Australia.
Sasso G; Radiation Oncology Department, Auckland City Hospital, New Zealand.
De Abreu Lourenco R; Centre for Health Economics Research and Evaluation, University of Technology Sydney, New South Wales, Australia.
Kron T; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.; Radiation Oncology Centre, Princess Alexandra Hospital, Queensland, Australia.
Ball D; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.
Neeson P; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Victoria, Australia.; Cancer Immunology Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Pokaż więcej
Corporate Authors :
Stereotactic Ablative Fractionated Radiotherapy Versus Radiosurgery for Oligometastatic Neoplasia to the Lung (SAFRON) II Study Investigators
Źródło :
JAMA oncology [JAMA Oncol] 2021 Aug 29. Date of Electronic Publication: 2021 Aug 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Randomized Clinical Trials in the Era of Precision Oncology-The Role of End Points, Industry Funding, and Medical Writing Integrity.
Autorzy :
Stewart DJ; University of Ottawa, Ottawa, Ontario, Canada.
Wheatley-Price P; University of Ottawa, Ottawa, Ontario, Canada.
Pokaż więcej
Źródło :
JAMA oncology [JAMA Oncol] 2021 Aug 26. Date of Electronic Publication: 2021 Aug 26.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies